Finnish independent game developer Remedy Entertainment has released its financial results for the first half of 2026, revealing a significant downturn in revenue while simultaneously showcasing promising early indicators for its highly anticipated sequel, CONTROL Resonant. The studio, renowned for creating atmospheric narrative-driven experiences, reported that second-quarter revenue plummeted by 40 percent year-over-year, dropping from €16.9 million to just €10.2 million. Despite these challenging numbers, the company maintains an optimistic outlook as it prepares for one of its most important releases in recent memory.
The full first half of 2026 painted a similarly challenging picture, with total revenue declining by 23.1 percent to €23.3 million compared to €30.3 million during the same period last year. However, Remedy managed to maintain marginally positive EBITDA at €0.5 million, and cash flow from operations actually improved to €7.6 million thanks to favorable timing of incoming payments. This financial performance reflects the cyclical nature of the video game industry, where development studios often experience revenue troughs between major releases while investing heavily in upcoming projects.
CONTROL Resonant Generates Unprecedented Pre-Release Interest
The most encouraging news from Remedy’s financial disclosure centers on CONTROL Resonant, the sequel to the 2019 critically acclaimed supernatural action-adventure game. The studio announced that wishlists for the upcoming title have surpassed 1.5 million across all platforms, representing exceptional consumer interest ahead of its September 24, 2026 launch date. This metric is particularly significant in the modern gaming landscape, as wishlist numbers have become a key indicator of potential commercial success and help developers gauge marketing effectiveness and allocate resources accordingly.
The original CONTROL was a breakthrough success for Remedy, winning numerous Game of the Year awards and establishing a new intellectual property that resonated deeply with players who appreciated its unique blend of paranormal investigation and stylish third-person combat. Set within the mysterious Federal Bureau of Control headquarters known as the Oldest House, the game introduced players to a shape-shifting brutalist building filled with supernatural phenomena called Altered World Events. The sequel promises to expand upon this foundation while introducing new mechanics and storylines that have generated substantial buzz within the gaming community.
Alan Wake 2 Continues Strong Performance with 3 Million Units Sold
Remedy also highlighted the continued success of Alan Wake 2, which has now sold over 3 million copies worldwide. This psychological horror sequel, released in late 2023, represented a major milestone for the studio as their first self-published title in partnership with Epic Games Publishing. The game received universal critical acclaim and won numerous awards, including multiple Game of the Year recognitions from major gaming publications. The sustained sales performance demonstrates the enduring appeal of Remedy’s narrative craftsmanship and their ability to create memorable gaming experiences that resonate with audiences long after release.
Alan Wake 2 marked a significant evolution in Remedy’s approach to game development, featuring a dual-protagonist structure that alternated between returning writer Alan Wake and new character FBI agent Saga Anderson. The game’s innovative blend of live-action sequences with traditional gameplay elements showcased Remedy’s willingness to push creative boundaries. With 3 million units sold and counting, the title has exceeded industry expectations and solidified Remedy’s reputation as a premier developer of story-driven games.
Looking Ahead: Remedy’s Multi-Project Strategy
The revenue decline reflects the natural development cycle as Remedy focuses resources on completing CONTROL Resonant and other unannounced projects. Industry analysts note that independent studios frequently experience such financial fluctuations between major releases, particularly when investing heavily in ambitious AAA productions. Remedy’s maintained positive cash flow suggests prudent financial management during this transitional period, positioning the company well for the anticipated revenue surge following CONTROL Resonant’s launch.
Remedy has also been expanding its development capacity and exploring the connected universe concept, linking their various properties including Control, Alan Wake, and potentially other franchises. This ambitious creative vision, combined with their proven track record and the enthusiastic consumer response to CONTROL Resonant, suggests the studio remains well-positioned despite current revenue challenges. The September launch will be crucial in determining whether the substantial wishlist numbers translate into commercial success that can fuel Remedy’s continued growth and creative ambitions.
Expert Opinion: The 1.5 million wishlists for CONTROL Resonant represent a strong foundation for commercial success, particularly given the original game’s dedicated fanbase and critical acclaim. If conversion rates align with industry standards of 10-20 percent, Remedy could see first-month sales exceeding 150,000-300,000 units, with the September launch window positioning the title favorably ahead of the crowded holiday season. The combination of Alan Wake 2’s continued momentum and CONTROL Resonant’s promising early metrics suggests Remedy’s financial position should strengthen considerably by year-end 2026.
